Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea · Delayed Price · Currency is KRW 436,500
+22,000 (5.31%)
May 21, 2026, 3:30 PM KST
Hanmi Pharm. Company Description
Hanmi Pharm. Co., Ltd. operates as a pharmaceutical company worldwide. It develops treatments for diabetes, obesity, cancer, autoimmune, and rare diseases. The company was founded in 1973 and is based in Seoul, South Korea.
Hanmi Pharm. Co., Ltd.
| Country | South Korea |
| Founded | 1973 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Jae-Hyun Park |
Contact Details
Address: 214 Muha-ro Hwaseong-si South Korea | |
| Phone | 82 3 1350 5600 |
Stock Details
| Ticker Symbol | 128940 |
| Exchange | Korea Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7128940004 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jae-Hyun Park | Chief Executive Officer and Director |
| Lim Chong-Yoon | President of Business Development and Executive Director |
| Jong-Hoon Lim | CSR Executive Director |
| Byung-hwa Shim | Chief Finance Officer |
| Yang-Hwan Choi | Group Head of IR |
| Jong-Soo Woo Ph.D. | Executive Director |
| Jong-Hoon Lim | Executive Director and Management Planning /CIO |
| Chang-Ju Choi | Vice President of Information Management Team |